Untapped Potential: Exploring Biosimilars for the Treatment of Retinal Diseases
home / case-based-roundtable-series / untapped-potential-exploring-biosimilars-for-the-treatment-of-retinal-diseases
Dr Rishi Singh provided valuable insights into the utilization of anti-VEGF biosimilars for managing Age-Related Macular Degeneration (AMD) and Diabetic Macular Edema (DME) and shares two patient cases that showcase the anatomic and visual improvement achieved by using a ranibizumab biosimilar.
EP. 2: Visual and Anatomic Improvement with a Ranibizumab Biosimilar
November 28th 2023Rishi Singh, MD, presents a case of neovascular age-related macular degeneration and diabetic macular edema demonstrating how the use of ranibizumab biosimilars can yield remarkable anatomical improvements comparable to those expected with reference biologics.
